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Purpose or Objective: Surgical implant fixation is a common 
technique in case of spinal and paraspinal tumors, usually 
considered good candidates for particle therapy 
(PT).Traditional orthopedic metal implants significantly differ 
from normal tissues in terms of density and composition, 
leading to substantial perturbation effects on radiation 
beams. Recently a Carbon Fibers Reinforced(CFR)-PEEK 
stabilization device completely metal free has become 
available (CarboFix Orthopedics). This device is supposed to 
be more suitable for PT where treatment accuracy can be 
highly compromised by uncertainties in particles range. The 
aim of this study was to investigate and compare 
uncertainties related to the use of titanium and CFR-PEEK 
screws in terms of image quality, reconstruction artifacts, 
contouring and dose calculation accuracy, for both proton 
and carbon ion beams. 
 
Material and Methods: Two vertebral body models, hosting 
two different types of orthopedic implants (a titanium and a 
CFR-PEEK implant), were positioned inside a water phantom 
to simulate real patients configuration. A CT scan was 
acquired according to our clinical protocols to evaluate 
induced HU artifacts and their impact on contouring 
uncertainties. Titanium and CFR-PEEK water equivalent path 
lengths (WEPL) were measured and implemented in our 
treatment planning systems (TPS). Implants and artifacts 
were contoured for proper material density assignment in the 
TPS HU to WEPL calibration curve. Plans were optimized for 
both proton and carbon ions, with and without HU correction, 
to evaluate the impact of CT artefacts and contouring 
uncertainties on dosimetric calculation accuracy, in 
comparison with MC simulations. Two patient cases, 
previously treated in our center were analyzed in terms of 
target and OAR dose deviation due to wrong material 
assignment, with respect to the clinically approved plan. 
 
Results: CFR-PEEK implants did not cause appreciable HU 
artifacts on CT images compared to titanium ones. Significant 
differences in dose distribution between TPS and MC 
simulations in high-Z region were observed, while a good 
agreement was found for CFR-PEEK screws. Inaccurate 
material assignment did not significantly vary the clinical 
case 3D dose distribution for CFR-PEEK implants (<1%). 
Titanium screws made difficult to correctly contour both 
targets and OARs. Moreover, local dose deviations up to 20% 
can be find when HU uncertainties are not correctly 
managed. Besides efforts made towards a robust optimization 
with respect to potential beam perturbation, dose delivered 
to healthy tissues positioned behind targets along the implant 
trajectory can be substantially altered. 
 
Conclusion: CFR-PEEK stabilization devices are more suitable 
than commonly-used titanium devices for PT of patients with 
orthopedic implants, leading to less image alteration and 
consequently reduced contouring uncertainties together with 
a significantly higher dosimetric treatment planning 
accuracy. 
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Purpose or Objective: To compare dosimetry plans using a 
commercially model based dose calculation algorithm 
(MBDCA) following TG186 recommendations, and the 
conventional TG43 method in an 192Ir high dose rate (HDR) 
brachytherapy (BT) procedure for the treatment of skin 
lesions. 
 
Material and Methods: Plesiotherapy treatment was 
performed in three patients with lesions localized in the pre 
auricular region (patient 1), the nasal dorsum (patient 2) and 
the nasal tip (patient 3). The lesions (PTV) were marked with 
radiopaque markers. Patients were immobilized with a 
thermoplastic mask. A bolus slab of 2 mm thickness and 
plastic catheters were applied over the mask, and the whole 
set was fixed with two bolus slabs. All dosimetries plans were 
based on a CT with 1,25mm slices thickness and the dose was 
delivered with a micro-Selectron afterloader. Treatment 
plans were performed using both the TG43 and TG186 dose 
calculation methods of the Oncentra Brachy v4.5 treatment 
planning system (TPS). Analysis included dose to the OARs 
(lens, ocullar globe and optic nerves) and to the prescription 
points (3 mm tissue depth). The TG186 results were obtained 
using the standard accuracy level option of model-based 
algorithm (Oncentra Brachy-Advanced Collapsed cone Engine 
(ACE), Elekta), resulting in calculation times between 7 – 10 
min. 
 
Results: In all cases, TG 43 overestimated the doses in the 
prescription points and in the OARs, in the range of 3.0% and 
6.2%, respectively (Figure 1). 
 
 
 
Conclusion: Although differences were found between the 
dosimetrie plans obtained with the TG43 and model based 
dose calculation algorithm following TG186 
recommendations, they are minor in terms of prescription 
dose points for skin lesions, since a 5% difference is within 
clinical tolerances in brachytherapy. 
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Purpose or Objective: At the introduction of RapidArc (RA) 
technique, the paper by Ling et al 2008 has constituted a 
reference, proposing RA commissioning machine quality 
assurance (QA) tests. Thanks to the free availability, many 
centers have implemented these tests in their periodic QA. 
Recently, tests identified as T2 (variation of dose rate DR and 
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gantry speed GS) and T3 (variation of MLC Speed MLCS) were 
updated. Even so, we decided to redraw completely T2 and 
T3, in the respect of the effective main concept. A family of 
new plans was generated to guarantee flexibility in the QA 
procedure and to support the user in a possible 
troubleshooting. 
 
Material and Methods: Firstly, a historical review of 
commissioning tests results on 3 different Varian linacs 
(Clinac iX, Unique, TrueBeam) was collected, for both old 
(2008: vs1) and new (2015: vs2) Varian test versions; original 
tests were extended to 10MV, 6FFF and 10FFF beams for 
TrueBeam. Data were collected monthly through portal vision 
(PV) images , for respectively 81, 21, and 42 entries for vs1. 
At the same, delivery parameters were extracted from actual 
patients plans (3911plans, 6833arcs) and stratified according 
to the types of treatment. From our experience, we felt the 
needs to have a more flexible instrument tuned on our 
clinical practice, able to support us in a possible 
troubleshooting. A family of new T2 and T3 plans was 
generated. In addition to the traditional analysis of the 
images, a direct comparison with the open reference field is 
proposed to define a more reliable baseline for the 
monitoring of each strip trend. 
 
Results: First version of the test T2 and T3, have presented 
during time differences respect reference value>2% 
(always<3%), for Clinac iX and Unique, while TrueBeam data 
were always <2%. The first T2 band presents a systematically 
higher value respect the others, explainable with some 
weakness in the test itself. Vs2 of T2 and T3, showed an 
agreement well below 2% for all the three linacs, but still 
with a systematic higher value for the T2 first delivered strip. 
The delineation of the new package of RT-plans started from 
the tune of number and width of the strips; the best 
compromise was found with 5 strip of 2.8 cm. Now T2 and T3 
are fully compatible and can be superimposed, running also a 
T3 with the same DR-GS variation presents in T2. From this 
main plan version of T2 and T3, the new family of rt-plans 
allows to perform tests changing arc direction or/and MLC 
direction, while an additional basic editing of the dicom files 
allows to vary the main delivery parameters, in addition to 
order of the delivered combinations, arc range, MU/deg, etc, 
as independently as possible. 
 
Conclusion: The new package of RT-plans is proposed in the 
fully respect of the original idea by Ling, with the intent to 
offer a more effective tool adjustable to single centre 
characters. Of particular interested is the extension to FFF 
beams, which are widely used in stereotactic regimes. 
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Purpose or Objective: To assess the clinical implications of 
the Collapsed Cone algorithm implemented in the Masterplan 
Oncentra treatment-planning system in VMAT treatments of 
nasopharyngeal tumors (NPC).  
 
Material and Methods: Ten plans initially produced for 
patients with nasopharyngeal tumors with Pencil Beam 
Convolution (PBC) algorithm were retrospectively 
recalculated using the Collapsed Cone Convolution (CCC) 
algorithm. Clinical target volumes were considered as 
primary tumor, lymph nodes with high-risk of occult 
metastases and low-risk nodal regions. Corresponding 
planning target volumes (PTVs) were obtained by adding a 4-
mm margin. Radiotherapy was prescribed according to SIB 
technique with all PTVs irradiated simultaneously over 30 
daily fractions. Doses of 70.5 Gy (2.35 Gy/fraction), 60.0 Gy 
(2.0 Gy/fraction) and 55.5 Gy (1.85 Gy/fraction) were 
prescribed to the PTV70.5, PTV60.0, and 
PTV55.5,respectively. All SIB-VMAT plans were optimized 
using the “dual-arc” feature with 6MV photon energy. The 
differences in dose distribution for all PTVs and organ-at-risk 
were assessed using different metrics (D95%=dose to 95% of 
PTV, D98%=near-minimum, Dmean=mean dose, V95%=volume 
receiving al least 95% of prescribed dose, D2%=near-maximum 
dose). The PTV70.5 was also separated into components in 
tissue (PTVtiss) and air (PTVair). Collapsed Cone plans were 
also renormalized (CCCr) in order to obtain the same target 
coverage in terms of D95% of PBC calculation. 
 
Results: PBC algorithm overestimated dose to PTVs for all 
considered metrics. The averaged Dmean and D95% to 
PTV70.5 calculated by CCC decreased by 1.8% (range:0.9%-
2.8%) and 3.1% (range:1.5%-5.3%), respectively (1.5% and 
2.8% lower for PTVtiss, and 5.5% and 8.6% lower for PTVair). 
Averaged D98% to PTV70.5 decreased by 3.4% (2.4% in tissue 
and 9.4% in air). Averaged V95% decreased from 96.0% to 
90.2% (from 96.1% to 91.2% for PTVtiss, and from 96.0% to 
70.9% for PTVair). The magnitude of dose differences are 
strongly correlated with the amount of air cavities in 
PTV70.5. A similar trend was observed for PTV60 and 
PTV55.5. Maximum doses to spine and brainstem PRVs were 
found to be approximately 1 Gy lower with CCC. The Dmean 
to pharyngeal constrictors muscles was found 4.7% higher 
with PBC. No differences were observed for parotids and 
mandible. PBC slightly underestimated the doses to eyes and 
lens (but ≤ 0.5 Gy). When the dose calculation were 
performed in water, the two algorithms provided differences 
in dose distributions <0.5%.  
 
 
